FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285041790> ?p ?o ?g. }

• W4285041790 abstract "Background Crohn’s disease (CD) is characterized by excessive protease activity and extracellular matrix (ECM) remodeling. To date, 30–50% of patients experience non-response to anti-TNF-α treatment. This study aimed to assess whether serological biomarkers of ECM turnover could monitor or predict response to infliximab (IFX) induction therapy in patients with and without a surgical history. Methods Serum biomarkers of type I (C1M), III (C3M), IV (C4M), and VI (C6Ma3) collagen degradation, type III (PRO-C3) and VI (PRO-C6) collagen formation, basement membrane turnover (PRO-C4), and T-cell activity (C4G), were measured at baseline and week 14, in 63 patients with CD undergoing IFX induction therapy. Patients were stratified according to surgical history. Results C4M was elevated at baseline in responders with a surgical history ( n = 10) and associated with response at baseline ( P &lt; 0.05). Additionally, C6Ma3, PRO-C3, and PRO-C6 were elevated at week 14 in responders compared with non-responders ( n = 8) and could differentiate between the two groups ( P &lt; 0.05). Two biomarker ratios (C4M/C4G and PRO-C4/C4G) were elevated at week 14 in non-responders ( n = 5) without a surgical history compared with responders ( n = 40) and could differentiate between the response groups ( P &lt; 0.05). Conclusion Baseline levels of a serological biomarker for type IV collagen degradation associated with response to IFX induction therapy, and biomarkers of type III and VI collagen formation may be used to monitor response at the end of induction therapy in patients with a surgical history. Biomarker ratios of type IV collagen turnover demonstrated promising results in monitoring treatment response in patients without a surgical history." @default.
• W4285041790 created "2022-07-13" @default.
• W4285041790 creator A5001756705 @default.
• W4285041790 creator A5003568842 @default.
• W4285041790 creator A5012839180 @default.
• W4285041790 creator A5022143308 @default.
• W4285041790 creator A5022143896 @default.
• W4285041790 creator A5028093768 @default.
• W4285041790 creator A5045244670 @default.
• W4285041790 creator A5056979971 @default.
• W4285041790 creator A5062054642 @default.
• W4285041790 creator A5063475809 @default.
• W4285041790 creator A5068944242 @default.
• W4285041790 creator A5069192514 @default.
• W4285041790 date "2022-07-12" @default.
• W4285041790 modified "2023-09-25" @default.
• W4285041790 title "Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease" @default.
• W4285041790 cites W15077488 @default.
• W4285041790 cites W1893181623 @default.
• W4285041790 cites W1940760407 @default.
• W4285041790 cites W1971685694 @default.
• W4285041790 cites W2010142532 @default.
• W4285041790 cites W2013090012 @default.
• W4285041790 cites W2046246972 @default.
• W4285041790 cites W2053006837 @default.
• W4285041790 cites W2056875960 @default.
• W4285041790 cites W2065752901 @default.
• W4285041790 cites W2066741376 @default.
• W4285041790 cites W2069533740 @default.
• W4285041790 cites W2098940019 @default.
• W4285041790 cites W2115865518 @default.
• W4285041790 cites W2143625465 @default.
• W4285041790 cites W2152671797 @default.
• W4285041790 cites W2195607455 @default.
• W4285041790 cites W2222546678 @default.
• W4285041790 cites W2293494973 @default.
• W4285041790 cites W2399328912 @default.
• W4285041790 cites W2409706327 @default.
• W4285041790 cites W2610753795 @default.
• W4285041790 cites W2749616891 @default.
• W4285041790 cites W2766973678 @default.
• W4285041790 cites W2782417153 @default.
• W4285041790 cites W2790539012 @default.
• W4285041790 cites W2802781128 @default.
• W4285041790 cites W2805686573 @default.
• W4285041790 cites W2886513786 @default.
• W4285041790 cites W2946291618 @default.
• W4285041790 cites W2977678162 @default.
• W4285041790 cites W3014716352 @default.
• W4285041790 cites W3091748034 @default.
• W4285041790 cites W3093590643 @default.
• W4285041790 cites W3114337463 @default.
• W4285041790 cites W3153096444 @default.
• W4285041790 cites W3155523632 @default.
• W4285041790 cites W3166758778 @default.
• W4285041790 cites W3186436044 @default.
• W4285041790 doi "https://doi.org/10.3389/fmed.2022.933872" @default.
• W4285041790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35903311" @default.
• W4285041790 hasPublicationYear "2022" @default.
• W4285041790 type Work @default.
• W4285041790 citedByCount "3" @default.
• W4285041790 countsByYear W42850417902023 @default.
• W4285041790 crossrefType "journal-article" @default.
• W4285041790 hasAuthorship W4285041790A5001756705 @default.
• W4285041790 hasAuthorship W4285041790A5003568842 @default.
• W4285041790 hasAuthorship W4285041790A5012839180 @default.
• W4285041790 hasAuthorship W4285041790A5022143308 @default.
• W4285041790 hasAuthorship W4285041790A5022143896 @default.
• W4285041790 hasAuthorship W4285041790A5028093768 @default.
• W4285041790 hasAuthorship W4285041790A5045244670 @default.
• W4285041790 hasAuthorship W4285041790A5056979971 @default.
• W4285041790 hasAuthorship W4285041790A5062054642 @default.
• W4285041790 hasAuthorship W4285041790A5063475809 @default.
• W4285041790 hasAuthorship W4285041790A5068944242 @default.
• W4285041790 hasAuthorship W4285041790A5069192514 @default.
• W4285041790 hasBestOaLocation W42850417901 @default.
• W4285041790 hasConcept C126322002 @default.
• W4285041790 hasConcept C159654299 @default.
• W4285041790 hasConcept C185592680 @default.
• W4285041790 hasConcept C189165786 @default.
• W4285041790 hasConcept C203014093 @default.
• W4285041790 hasConcept C2777138892 @default.
• W4285041790 hasConcept C2779134260 @default.
• W4285041790 hasConcept C2779280984 @default.
• W4285041790 hasConcept C2781197716 @default.
• W4285041790 hasConcept C45189115 @default.
• W4285041790 hasConcept C55493867 @default.
• W4285041790 hasConcept C71924100 @default.
• W4285041790 hasConcept C86803240 @default.
• W4285041790 hasConcept C90924648 @default.
• W4285041790 hasConcept C95444343 @default.
• W4285041790 hasConceptScore W4285041790C126322002 @default.
• W4285041790 hasConceptScore W4285041790C159654299 @default.
• W4285041790 hasConceptScore W4285041790C185592680 @default.
• W4285041790 hasConceptScore W4285041790C189165786 @default.
• W4285041790 hasConceptScore W4285041790C203014093 @default.
• W4285041790 hasConceptScore W4285041790C2777138892 @default.
• W4285041790 hasConceptScore W4285041790C2779134260 @default.
• W4285041790 hasConceptScore W4285041790C2779280984 @default.
• W4285041790 hasConceptScore W4285041790C2781197716 @default.

• next